Donor-derived CD19 CAR-T cell therapy of relapse of CD19-positive B-ALL post allotransplant - Zhang, Cheng; Wang, Xiao-Qi; Zhang, Rong-Li; Liu, Fang; Wang, Yi; Yan, Zhi-Ling; Song, Yong-Ping; Yang, Ting; Li, Ping; Wang, Zhen; Ma, Ying-Ying; Gao, Lei; et al. (Leukemia, 2021)
Keywords: 38/77; 45/100; 631/67/1059/2325; 692/699/1541/1990/283/2125; Acute lymphoblastic leukemia; Acute lymphocytic leukemia; Antigen receptors, T cell; Antigens; Cancer; Cancer Research; Care and treatment; CD19 antigen; Cell therapy; Cellular therapy; Chimeric antigen receptors; Confidence intervals; Critical Care Medicine; Cytokines; Development and progression; Graft-versus-host reaction; Health aspects; Hematology; Intensive; Internal Medicine; Leukemia; Lymphatic leukemia; Lymphocytes; Lymphocytes B; Lymphocytes T; Medicine; Medicine & Public Health; Methods; Neurotoxicity; Oncology; Oncology, Experimental; Patient outcomes; Receptors; Remission; Survival; T cells; China